Sign in Subscribe
Pregnant women

Acetaminophen and Autism: Separating Fact from Fiction

Strategic Insights

— 2 min read

As the debate surrounding acetaminophen use in pregnancy and autism continued to unfold, global health agencies stepped in to calm the growing anxiety among pregnant women. President Donald Trump's statement urging them to avoid Tylenol resurrected debunked doubts about vaccines and tied acetaminophen use in pregnancy to autism. However, the World Health Organization, European Medicines Agency, and other regulatory bodies maintained that there is no conclusive scientific evidence that acetaminophen use in pregnancy causes autism.

Key Takeaways:

  • The World Health Organization has stated that there is no conclusive scientific evidence that acetaminophen use in pregnancy causes autism.
  • European Medicines Agency guidance on the use of paracetamol during pregnancy remains unchanged, emphasizing the importance of using the smallest dose for the shortest necessary time and consulting with a clinician.
  • The US Food and Drug Administration has opened a process to add precautionary language to labels, while emphasizing that causation has not been established.
  • Acetaminophen has been the default over-the-counter option for pain and fever in pregnancy due to the potential risks associated with alternatives like ibuprofen and aspirin.
  • Observational studies have reported a statistical association between prenatal exposure to acetaminophen and later diagnoses of neurodevelopmental conditions, but these findings are vulnerable to confounding and may be influenced by factors such as fever, infection, and socioeconomic conditions.
  • A large population-based study published in JAMA in 2024 found no increased risk of autism, ADHD, or intellectual disability associated with acetaminophen exposure in matched sibling pairs.
  • Regulators across agencies emphasize the importance of using medicines in pregnancy only when necessary, and using the smallest dose for the shortest necessary time.
  • Clinicians must balance the potential risks and benefits of using acetaminophen in pregnancy, depending on the individual patient's history, symptoms, and gestational age.

Statistics:

  • The CDC's 2025 surveillance estimated that among 8-year-olds in 2022, prevalence of autism averaged about one in 31 across its monitoring sites, higher in some regions and lower in others.
  • The FDA has opened a process to add precautionary language to labels, which may be approved in the coming months.
  • The US Food and Drug Administration has stated that causation has not been established between acetaminophen use during pregnancy and autism.
  • The World Health Organization has emphasized the importance of evidence-based decision-making and has stated that there is no conclusive scientific evidence that acetaminophen use in pregnancy causes autism.

Sources:

  • World Health Organization (2025). Statement on Autism-Related Issues.
  • European Medicines Agency (2025). Use of Paracetamol During Pregnancy: Unchanged EU Guidance.
  • US Food and Drug Administration (2025). Response to Evidence of Possible Association Between Autism and Acetaminophen Use During Pregnancy.
  • American College of Obstetricians and Gynecologists (2025). Acetaminophen Safety and Benefits in Pregnancy.
  • Centers for Disease Control and Prevention (2025). Autism Prevalence Estimates Among 8-Year-Olds.

Read more